← Back to Stock Screener← Stock Screener

ZYBERNO

Stock Report

Updated Aug 31, 2026

Accendra Health, Inc. (ACH)

Consumer Discretionary • NYSE

$1.21

Professional Investment Analysis

ZYBERNO SCORE →

Is it a great business? Is it getting better?

7.0/100

POOR BUSINESS

Accendra Health, Inc. (ACH) scores 7/100 — concerning metrics indicating significant structural or financial risks.

📊 How is the Zyberno Score calculated? +

The Zyberno Score answers one question: "Is this a quality business worth owning?" It's a 0-100 investment grade that evaluates business fundamentals across four critical dimensions, based on principles from Warren Buffett, Benjamin Graham, Peter Lynch, and Charlie Munger.

The 4 Core Categories (25 points each):

1. PROFITABILITY (25 pts)

Metrics: ROE, ROIC, Net Margin, Operating Margin
Thresholds: ROE >20% excellent • ROIC >20% excellent • Net Margin >20% excellent • Operating Margin >25% excellent

2. FINANCIAL STRENGTH (25 pts)

Metrics: Debt-to-Equity, Current Ratio, Interest Coverage, Altman Z-Score
Thresholds: D/E <0.3 excellent • Current Ratio >2.5 excellent • Interest Coverage >10x excellent • Altman Z >3.0 safe

3. CASH FLOW QUALITY (25 pts)

Metrics: Free Cash Flow, OCF vs Net Income, FCF Margin
Thresholds: Positive & growing FCF excellent • OCF/NI >1.2x excellent (cash earnings exceed accounting)

4. GROWTH & CONSISTENCY (25 pts)

Metrics: Revenue Growth, Net Income Growth, FCF Growth, Piotroski F-Score
Thresholds: Growth via log-linear regression • Piotroski 8-9 excellent, 6-7 good

Score Interpretation:

75-100

GREAT BUSINESS

65-74

GOOD BUSINESS

50-64

AVERAGE BUSINESS

30-49

WEAK BUSINESS

0-29

POOR BUSINESS

→ View full ACH quality analysis & detailed breakdown

VALUATION SIGNAL

MARGIN OF SAFETY

Is this stock cheap or expensive relative to what the business has historically generated for owners?

Margin of Safety unavailable — insufficient data for the owner-earnings DCF.

BRINA GAP ↗

Is the market underestimating or overestimating what this business is capable of going forward?

-45.7%

Market Overestimates

💰 How is Margin of Safety calculated? +

Margin of Safety measures how much discount or premium you're paying relative to a stock's intrinsic value. It's Benjamin Graham's core principle: the larger the margin, the lower your downside risk.

Formula: (Intrinsic Value − Current Price) ÷ Intrinsic Value × 100%

How We Calculate Intrinsic Value (DCF Method):

Step 1: Calculate current Owner Earnings (OCF − Maintenance CapEx)

Step 2: Calculate company-specific growth rate using log-linear regression on 16 quarters of Owner Earnings

Step 3: Project 10 years forward using the calculated growth rate

Step 4: Discount each year's cash flow to present value using 10% discount rate

Step 5: Calculate terminal value using 3% perpetual growth rate

Step 6: Sum all discounted cash flows = Intrinsic Value

What The Percentages Mean:

+50% or more

EXCELLENT — Very undervalued

+25% to +50%

GOOD — Attractive discount

0% to +25%

FAIR — Reasonable value

0% to -25%

CAUTION — Slight premium

-25% or worse

POOR — Overvalued

"Price is what you pay, value is what you get." — Warren Buffett

→ View full ACH valuation analysis · → View full ACH Brina Gap analysis

📈 How is Brina Gap calculated? +

Brina Gap measures the difference between the growth a business can fundamentally sustain and the growth the market is already pricing in.

Formula: Fundamental Growth Rate − Market-Implied Growth Rate

The Two Components:

Fundamental Growth Rate = ROIC × Reinvestment Rate

What the business can sustainably grow at based on how much it reinvests and what return it earns on that capital. Grounded in historical financials.

Market-Implied Growth Rate = Reverse DCF

The growth rate the current Enterprise Value implicitly assumes. Calculated by back-solving a 10-year DCF model (10% WACC, 3% terminal growth) until the present value of projected cash flows equals EV.

What The Gap Means:

Gap > +5% Market Underestimates — potential upside

+2% to +5% Slight Underestimate

-2% to +2% Fairly Priced — market consensus matches fundamentals

-5% to -2% Slight Overestimate

Gap < -5% Market Overestimates — price embeds optimism fundamentals don't support

A positive gap (market underestimates) combined with a positive Margin of Safety is the strongest combined signal — the business is both cheap historically and forward economics are stronger than the price suggests.

Critical Financial Health Indicators

Return on Equity (Profitability):CRITICAL (0.0%)

Debt-to-Equity (Solvency Risk):EXCELLENT (0.00x)

Operating Margin (Operational Efficiency):CRITICAL (1.2%)

Return on Capital (Capital Efficiency):CRITICAL (2.6%)

📊 Valuation Trilogy

Three interconnected metrics for complete valuation analysis

Click any metric for full methodology and detailed analysis

Zyberno's Verdict

Accendra Health, Inc. (ACH) stock report — Zyberno Score 7/100 (POOR BUSINESS). Full financial analysis on Zyberno.

According to Zyberno's DCF model, Accendra Health, Inc. (ACH) shows a Brina Gap of -45.7%, which weakens the case: based on the company's ROIC (2.6%) and reinvestment rate (-946.1%), the business can fundamentally grow at -24.3% — but the current enterprise value implies the market expects 21.4%.

DIVISION I: EXECUTIVE SUMMARY

A. Market Valuation

Market Price & Capitalization (2)

Current Price:1.21

Market Cap:$92.80M

Valuation Multiples (2)

P/S Ratio:0.02x

Peg Ratio:-999.00x

Enterprise Metrics (2)

Enterprise Value:$2.07B

Ev Ebitda Ratio:5.28x

Price Action & Momentum (3)

12-1 Momentum:

-53.1% (5th pctile)

📈 Click to view full ACH Momentum analysis →

Momentum Percentile:5 / 100

% of 52-Week High:21.3%

B. Profitability Assessment

Return Metrics (6)

ROA:-11.0%

Roic:

2.6%

📊 Click to view full ACH ROIC analysis →

Reinvestment Rate:-946.1%

Fundamental Growth Rate (g):-24.3%

Market-Implied Growth Rate:21.4%

Brina Gap:

-45.7%

☷ Click to view full ACH Brina Gap analysis →

Margin Analysis (3)

Operating Margin Ttm:1.2%

Net Margin Ttm:-7.5%

Ebitda Margin:9.8%

TTM Performance (3)

Gross Margin Ttm:55.2%

Operating Margin Ttm:1.2%

Net Margin Ttm:-7.5%

Yield Metrics (2)

Earnings Yield:-$354.05

Dividend Yield:0.0%

C. Log-Linear Regression Growth Trends

Earnings Surprise (SUE) (3)

Earnings Surprise (SUE):

+3.96

📊 Click to view full ACH Earnings Surprise analysis →

EPS Surprise vs Expected:90.6%

Latest Earnings Filed:2026-08-10

Revenue Growth (Linear) (1)

Revenue Growth Rate (Linear):-30.7%

Cash Flow Growth (Linear) (2)

Free Cash Flow Growth Rate (Linear):-8.0%

Operating Cash Flow Growth Rate (Linear):3.2%

Operating Growth (Linear) (1)

Operating Income Growth Rate (Linear):-30.9%

D. Financial Stability

Liquidity Ratios (3)

Current Ratio:0.41x

Quick Ratio:0.30x

Cash Ratio:0.01x

Leverage Analysis (1)

Debt To Ebitda:5.06x

Coverage Ratios (2)

Interest Coverage Ratio:0.24x

Times Interest Earned:0.24

Capital Structure (4)

Working Capital:-394,767,000.00

Cash And Cash Equivalents:7,651,000.00

Long Term Debt:$1.72B

Net Debt:$1.98B

DIVISION II: FINANCIAL STATEMENTS ANALYSIS

A. Income Statement Analysis

Revenue Components (2)

Revenue TTM: $4.00B

Linear Growth: -30.7%

📊 Click to view full ACH Revenue analysis & methodology →

Cost Of Revenue Ttm:$2.17B

Profitability Breakdown (2)

Gross profit TTM: $2.21B

Linear Growth: 13.6%

📊 Click to view full ACH Gross Profit analysis & methodology →

Operating income TTM: $49.02M

Linear Growth: -30.9%

📊 Click to view full ACH Operating Income analysis & methodology →

Bottom Line Performance (3)

-$302.14M

Income Before Tax:-$205.83M

Ebitda Ttm:393,021,000.00

Operating Expenses (5)

Operating Expenses:2,651,460,000.00

R And D Expense:13,000,000.00

Sga Expense:836,141,000.00

Income Tax Expense:$3.61M

Interest Expense:114,102,000.00

Expense Ratios (3)

R And D To Revenue Percentage:2.1%

Sga To Revenue Percentage:136.3%

Ebitda Margin:9.8%

B. Balance Sheet Analysis

Asset Composition (5)

Total Assets:$2.11B

Current Assets:$271.45M

Ppe Net:208,666,000.00

Goodwill:1,228,140,000.00

Intangible Assets:$78.01M

Liability Structure (4)

Total Liabilities:2,658,350,000.00

Current Liabilities:666,216,000.00

Long Term Debt:$1.72B

Short Term Debt:$271.59M

Equity & Capital (3)

Equity:-$550.94M

Retained Earnings:-$1.18B

Common Stock:153,809,000.00

Working Capital Items (3)

Accounts Receivable:0.00

Inventory:73,345,000.00

Accounts Payable:352,798,000.00

Special Items (2)

Contract Liabilities:41,700,000.00

Stock Based Compensation:3,090,000.00

C. Cash Flow Analysis

Operating Activities (2)

Operating cash flow TTM: -$101.79M

Linear Growth: 3.2%

Free cash flow TTM: -$292.75M

Linear Growth: -8.0%

📊 Click to view full ACH Free Cash Flow analysis & methodology →

Investment Activities (1)

Investing Cash Flow:$53.93M

Financing Activities (3)

Financing Cash Flow:$51.08M

Dividends Paid Ttm:0.00

Stock Repurchase:0.00

Capital Transactions (3)

Common Stock Issuance:0.00

Long Term Debt Issuance:$0.00

Long Term Debt Repayments:$244.20M

Non-Cash Items (1)

Depreciation Amortization Ttm:344,000,000.00

DIVISION III: OPERATIONAL METRICS

A. Per Share Analysis

Earnings Per Share (3)

EPS (Basic TTM):-3.93

-$3.93

Earnings Per Share Ttm:-$3.94

Revenue & Cash Per Share (2)

Sales Per Share Ttm:52.19

Operating Cash Flow Per Share:-$1.33

Book Value & Capital (2)

Book Value Per Share:-$7.18

Cash Per Share:0.10

Dividend Policy (1)

Dividend Payout Ratio:-999.00x

B. Operational Efficiency

Asset Utilization (2)

Asset Turnover Ttm:1.45x

Working Capital Turnover Ttm:-999.00x

Receivables Management (2)

Receivables Turnover Ttm:-999.00x

Days Sales Outstanding Ttm:-999.00

Inventory Management (2)

Inventory Turnover Ttm:29.62x

Days Inventory Outstanding Ttm:12.32

Payables & Cash Cycle (2)

Days Payable Outstanding:59.28

Cash Conversion Cycle:-1,045.95

C. Quality & Risk Metrics

Financial Quality Scores (2)

Financial Strength Score:0.00

Quality Score:15.00

Market Metrics (2)

Beta:0.00x

Volatility Category:unknown

DIVISION IV: INVESTMENT ANALYSIS

A. Value Investment Framework

Damodaran Growth Analysis (4)

Reinvestment Rate:-946.1%

Fundamental Growth Rate (g):-24.3%

Market-Implied Growth Rate:21.4%

Brina Gap:

-45.7%

☷ Click to view full ACH Brina Gap analysis →

B. Log-Linear Regression Growth Analysis

Growth Rates (Log-Linear Regression) (2)

Revenue Growth Rate (Linear):-30.7%

Operating Income Growth Rate (Linear):-30.9%

Cash Flow Growth Rates (2)

Free Cash Flow Growth Rate (Linear):-8.0%

Operating Cash Flow Growth Rate (Linear):3.2%

Other Growth Rates (2)

Gross Profit Growth Rate (Linear):13.6%

Book Value Growth Rate (Linear):-13.3%

C. Company Profile & Context

Corporate Information (6)

Symbol:ACH

Company Name:Accendra Health, Inc.

Sector:Consumer Discretionary

Industry:Wholesale-Medical, Dental & Hospital Equipment & Supplies

Exchange:NYSE

Country:United States

Market Classification (3)

Market Cap Category:N/A

Price Category:low

Volume Category:N/A

Share Structure (3)

Shares Outstanding:76.70M

Shares Outstanding Basic:76.70M

Shares Outstanding Diluted:76.70M

Data Processing Info (3)

Processing Version:v3.0

Last Updated:2026-08-31 08:07:32 UTC

Data Timestamp:2026-08-18T21:09:28.266701